Cargando…

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression

BACKGROUND: One prominent event associated with colorectal adenoma-to-carcinoma progression is genomic instability. Approximately 85% of colorectal cancer cases exhibit chromosomal instability characterized by accumulation of chromosome copy number aberrations (CNAs). Adenomas with gain of chromosom...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Wit, Meike, Carvalho, Beatriz, Delis-van Diemen, Pien M., van Alphen, Carolien, Beliën, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421768/ https://www.ncbi.nlm.nih.gov/pubmed/28481899 http://dx.doi.org/10.1371/journal.pone.0174768

Ejemplares similares

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
por: Sillars-Hardebol, Anke H., et al.
Publicado: (2010)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
por: Vleugels, Jasper L.A., et al.
Publicado: (2019)

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
por: Jodal, Henriette C., et al.
Publicado: (2023)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
por: Komor, Malgorzata A., et al.
Publicado: (2019)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
por: Goos, Jeroen A.C.M., et al.
Publicado: (2015)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Sluiter, N. R., et al.
Publicado: (2016)

Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression
por: Komor, Malgorzata A, et al.
Publicado: (2020)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
por: Lenos, Kristiaan, et al.
Publicado: (2015)

Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism
por: Carvalho, Beatriz, et al.
Publicado: (2012)

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)

Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2022)

tranSMART
por: Bierkens, Mariska, et al.
Publicado: (2015)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

Comprehensive Mutation Analysis in Colorectal Flat Adenomas
por: Voorham, Quirinus J. M., et al.
Publicado: (2012)

Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021)

Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma
por: Zang, Yiqing, et al.
Publicado: (2021)

Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma
por: Yamauchi, Naoto, et al.
Publicado: (2021)

Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican
por: Chakravarti, Shukti, et al.
Publicado: (1998)

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
por: Voorham, Quirinus JM, et al.
Publicado: (2013)

The Role of Lumican in Ocular Disease
por: Amjadi, Shahriar, et al.
Publicado: (2013)

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
por: van den Broek, Evert, et al.
Publicado: (2015)

Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer
por: Jacobsen, Annika, et al.
Publicado: (2018)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
por: Fijneman, Remond J. A.
Publicado: (2005)

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes
por: van den Broek, Evert, et al.
Publicado: (2017)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
por: van der Meijde, Elisabeth, et al.
Publicado: (2016)

Versican Expression during Synovial Joint Morphogenesis
por: Shepard, John B., et al.
Publicado: (2007)

Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
por: Chang, Wenjing, et al.
Publicado: (2023)

Lumican Expression in Diaphragm Induced by Mechanical Ventilation
por: Li, Li-Fu, et al.
Publicado: (2011)

Lumican Is Overexpressed in Lung Adenocarcinoma Pleural Effusions
por: Cappellesso, Rocco, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hh6rtqsj29krccghbd9i3l20p2